Wim Martinet Selected Research

Metformin (Glucophage)

11/2016	Potential therapeutic effects of mTOR inhibition in atherosclerosis.
1/2015	Autophagy in vascular disease.
4/2014	mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wim Martinet Research Topics

Disease

48	Atherosclerotic Plaque (Atheroma) 05/2024 - 06/2002
43	Atherosclerosis 05/2024 - 06/2002
15	Necrosis 05/2024 - 06/2006
12	Inflammation (Inflammations) 05/2024 - 02/2009
11	Rupture 01/2024 - 01/2005
8	Myocardial Infarction 03/2024 - 12/2014
7	Neoplasms (Cancer) 12/2022 - 06/2011
5	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 10/2016
4	Heart Failure 10/2023 - 01/2006
4	Hypertrophy 12/2021 - 08/2002
4	Sudden Death 07/2019 - 12/2014
4	Starvation 05/2012 - 08/2005
3	Fibrosis (Cirrhosis) 10/2023 - 01/2010
3	Hypertension (High Blood Pressure) 01/2022 - 09/2014
3	Ischemia 09/2020 - 09/2009
3	Brain Hypoxia (Cerebral Hypoxia) 07/2019 - 02/2015
3	Infections 01/2019 - 01/2017
3	Atrophy 09/2012 - 05/2008
2	Type 2 Diabetes Mellitus (MODY) 10/2023 - 05/2013
2	Hemorrhage 01/2022 - 01/2005
2	Pathologic Constriction (Stenosis) 01/2022 - 11/2015
2	Alzheimer Disease (Alzheimer's Disease) 06/2021 - 06/2002
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 03/2015
2	Myocardial Ischemia (Ischemic Heart Diseases) 07/2019 - 01/2018
2	Dyslipidemias (Dyslipidemia) 01/2018 - 04/2014
2	Vascular Diseases (Vascular Disease) 08/2016 - 01/2015
2	Stroke (Strokes) 05/2015 - 12/2014
2	Hypoxia (Hypoxemia) 02/2015 - 08/2007
2	Hyperglycemia 04/2014 - 04/2011
2	Critical Illness (Critically Ill) 05/2012 - 04/2011
2	Neuroblastoma 08/2007 - 12/2006
1	Cardiotoxicity 11/2023
1	Acute Coronary Syndrome 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022

Drug/Important Bio-Agent (IBA)

26	Apolipoproteins E (ApoE)IBA 05/2024 - 12/2009
19	Proteins (Proteins, Gene)FDA Link 03/2024 - 06/2002
11	LipidsIBA 05/2024 - 02/2009
11	ApolipoproteinsIBA 12/2021 - 01/2010
8	CholesterolIBA 01/2018 - 06/2003
6	Fibrillin-1IBA 12/2021 - 02/2015
6	Everolimus FDA Link 02/2019 - 02/2007
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 07/2010
5	Biomarkers (Surrogate Marker)IBA 03/2024 - 03/2015
5	CollagenIBA 01/2022 - 01/2010
5	Sirolimus (Rapamycin)FDA Link 02/2019 - 05/2012
5	TOR Serine-Threonine KinasesIBA 04/2014 - 02/2007
5	Messenger RNA (mRNA)IBA 04/2009 - 06/2002
4	CytokinesIBA 01/2024 - 05/2012
4	MTOR InhibitorsIBA 11/2016 - 07/2010
4	Protein Synthesis InhibitorsIBA 07/2010 - 03/2007
4	Cycloheximide (Cicloheximide)IBA 06/2009 - 08/2005
3	EnzymesIBA 01/2024 - 06/2002
3	ElastinIBA 01/2022 - 12/2014
3	Amyloid (Amyloid Fibrils)IBA 06/2021 - 06/2002
3	Nitric Oxide DonorsIBA 07/2019 - 06/2003
3	NeuroglobinIBA 01/2018 - 12/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 08/2002
3	Metformin (Glucophage)FDA LinkGeneric 11/2016 - 04/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2006 - 08/2005
2	IronIBA 05/2024 - 01/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 08/2021
2	Angiotensin IIIBA 01/2022 - 01/2020
2	Insulin (Novolin)FDA Link 06/2021 - 04/2011
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2017
2	UAMC-2526IBA 01/2021 - 01/2017
2	Molsidomine (SIN 10)IBA 07/2019 - 06/2003
2	Peptides (Polypeptides)IBA 01/2019 - 06/2002
2	VaccinesIBA 01/2019 - 01/2018
2	Neutralizing AntibodiesIBA 01/2019 - 01/2018
2	Oxygen (Dioxygen)IBA 01/2018 - 08/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 08/2002
2	SpermidineIBA 01/2016 - 01/2015
2	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 09/2011
2	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 05/2013 - 06/2006
2	Imiquimod (Aldara)FDA LinkGeneric 01/2013 - 05/2012
2	LigandsIBA 01/2013 - 05/2012
2	Glucose (Dextrose)FDA LinkGeneric 05/2012 - 08/2007
2	Protein AggregatesIBA 04/2011 - 09/2009
2	UbiquitinIBA 01/2010 - 01/2006
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2010 - 08/2009
2	Neuraminidase (Sialidase)IBA 08/2009 - 05/2008
2	PuromycinIBA 06/2009 - 06/2008
2	CytoglobinIBA 08/2007 - 12/2006
2	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 10/2006 - 06/2006
1	AntioxidantsIBA 05/2024
1	FibrillinsIBA 05/2024
1	Tocopherols (Tocopherol)IBA 05/2024
1	Beclin-1IBA 03/2024
1	Lipoproteins (Lipoprotein)IBA 01/2024
1	GasotransmittersIBA 12/2023
1	AnthracyclinesIBA 11/2023
1	Ferritins (Ferritin)IBA 11/2023
1	Heme Oxygenase-1IBA 11/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2023
1	empagliflozinIBA 10/2023
1	Auranofin (Ridaura)FDA Link 12/2022
1	Antineoplastic Agents (Antineoplastics)IBA 12/2022

Therapy/Procedure

12	Therapeutics 01/2024 - 06/2006
5	Stents 01/2015 - 02/2007
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2017